{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:41:23Z","timestamp":1791945683196,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H02846"],"award-info":[{"award-number":["21H02846"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2109"],"award-info":[{"award-number":["JPMJSP2109"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jad.2024.08.222","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T12:20:22Z","timestamp":1725366022000},"page":"745-755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-\u03b21"],"prefix":"10.1016","volume":"367","author":[{"given":"Dan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youge","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jad.2024.08.222_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2629","article-title":"Unraveling the mystery of white matter in depression: a translational perspective on recent advances","volume":"12","author":"Abraham","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.jad.2024.08.222_bb0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb0015","doi-asserted-by":"crossref","first-page":"34594","DOI":"10.1038\/srep34594","article-title":"B cell-derived transforming growth factor-\u03b21 expression limits the induction phase of autoimmune neuroinflammation","volume":"6","author":"Bjarnad\u00f3ttir","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jad.2024.08.222_bb0020","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","article-title":"Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability","volume":"26","author":"Bonaventura","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb0025","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.phrs.2018.02.007","article-title":"Neurobiological links between depression and AD: the role of TGF-\u03b21 signaling as a new pharmacological target","volume":"130","author":"Caraci","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jad.2024.08.222_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","article-title":"Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine","volume":"181","author":"Chang","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2024.08.222_bb0035","article-title":"Protection of TGF-\u03b21 against neuroinflammation and neurodegeneration in A\u03b21-42-induced Alzheimer\u2019s disease model rats","volume":"10","author":"Chen","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jad.2024.08.222_bb0040","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0014-4886(03)00308-X","article-title":"Transforming growth factor beta 1 may regulate the stability of mature myelin sheaths","volume":"184","author":"Day","year":"2003","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.jad.2024.08.222_bb0050","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/brainsci11010058","article-title":"Neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio in bipolar disorder","volume":"11","author":"Fusar-Poli","year":"2021","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.jad.2024.08.222_bb0065","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s11682-020-00345-z","article-title":"White matter correlates of slowed information processing speed in unimpaired multiple sclerosis patients with young age onset","volume":"15","author":"Govindarajan","year":"2021","journal-title":"Brain Imaging Behav."},{"issue":"7","key":"10.1016\/j.jad.2024.08.222_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022623","article-title":"Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming","volume":"6","author":"Gudi","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.jad.2024.08.222_bb0075","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/1673-5374.293147","article-title":"Glial-derived transforming growth factor \u03b21 (TGF-\u03b21): a key factor in multiple sclerosis neuroinflammation","volume":"16","author":"Guevara","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jad.2024.08.222_bb0080","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41869","article-title":"Circulating transforming growth factor-\u03b21 facilitates remyelination in the adult central nervous system","volume":"8","author":"Hamaguchi","year":"2019","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.jad.2024.08.222_bb0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.08.222_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.jad.2024.08.222_bb0095","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00406-023-01570-5","article-title":"Arketamine for cognitive impairment in psychiatric disorders","volume":"273","author":"Hashimoto","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.08.222_bb0100","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-024-01770-7","article-title":"Are \"mystical experiences\" essential for antidepressant actions of ketamine and the classic psychedelics?","author":"Hashimoto","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.jad.2024.08.222_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00406-016-0692-7","article-title":"Reduction of dopamine D2\/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys","volume":"267","author":"Hashimoto","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.08.222_bb0110","article-title":"White matter alterations in depressive disorder","volume":"13","author":"He","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jad.2024.08.222_bb6005","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/s41380-023-02288-5","article-title":"Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine","volume":"29","author":"Huang","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb9000","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-023-01732-5","article-title":"The correlation of Esketamine with specific adverse events: a deep dive into the FAERS database","author":"Jiang","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jad.2024.08.222_bb6010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00406-020-01110-5","article-title":"Intravenous arketamine for treatment-resistant depression: open-label pilot study","volume":"271","author":"Leal","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.jad.2024.08.222_bb6000","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.intimp.2006.03.015","article-title":"The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder","volume":"6","author":"Lee","year":"2006","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2024.08.222_bb8000","doi-asserted-by":"crossref","first-page":"516","DOI":"10.4306\/pi.2015.12.4.516","article-title":"Impact of white matter lesions on depression in the patients with Alzheimer's disease","volume":"12","author":"Lee","year":"2015","journal-title":"Psychiatry Investig."},{"issue":"5","key":"10.1016\/j.jad.2024.08.222_bb4000","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cpr.2010.04.010","article-title":"Stress generation in depression: A systematic review of the empirical literature and recommendations for future study","volume":"30","author":"Liu","year":"2010","journal-title":"Clin. Psychol. Rev."},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13287-020-01894-2","article-title":"Overexpressing TGF-\u03b21 in mesenchymal stem cells attenuates organ dysfunction during CLP-induced septic mice by reducing macrophage-driven inflammation","volume":"11","author":"Liu","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jad.2024.08.222_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173659","article-title":"Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress","volume":"233","author":"Liu","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2024.08.222_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.brainresbull.2007.06.021","article-title":"Intranasally delivered TGF-\u03b21 enters brain and regulates gene expressions of its receptors in rats","volume":"74","author":"Ma","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jad.2024.08.222_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2202-9-117","article-title":"Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone","volume":"9","author":"Ma","year":"2008","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41398-022-02192-6","article-title":"A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice","volume":"12","author":"Ma","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173736","article-title":"A role of gut-brain axis on prophylactic actions of arketamine in male mice exposed to chronic restrain stress","volume":"238","author":"Ma","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2024.08.222_bb0145","article-title":"The effects of chronic stress on health: new insights into the molecular mechanisms of brain-body communication","volume":"1(3):FSO23","author":"Mariotti","year":"2015","journal-title":"Future Sci. OA"},{"issue":"19","key":"10.1016\/j.jad.2024.08.222_bb0150","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jad.2024.08.222_bb0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamapsychiatry.2014.189","article-title":"Myelination and oligodendrocyte functions in psychiatric diseases","volume":"71","author":"Nave","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb0160","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.jad.2024.08.222_bb0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.comppsych.2011.04.004","article-title":"Temperaments mediate suicide risk and psychopathology among patients with bipolar disorders","volume":"53","author":"Pompili","year":"2012","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106348","article-title":"Role of the gut-brain axis via the subdiaphragmatic vagus nerve in stress resilience of 3,4-methylenedioxymethamphetamine in mice exposed to chronic restrain stress","volume":"189","author":"Qu","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jad.2024.08.222_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12974-016-0503-0","article-title":"TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function","volume":"13","author":"Rustenhoven","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0180","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/s41598-017-02062-y","article-title":"Myelination of the brain in major depressive disorder: an in vivo quantitative magnetic resonance imaging study","volume":"7","author":"Sacchet","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jad.2024.08.222_bb0185","article-title":"Neuropsychiatry in demyelination disease: using depression as a prodrome for early diagnosis and treatment of multiple sclerosis","volume":"9","author":"Shail","year":"2017","journal-title":"Cureus"},{"issue":"23","key":"10.1016\/j.jad.2024.08.222_bb0190","doi-asserted-by":"crossref","first-page":"e2042","DOI":"10.1212\/WNL.0000000000005644","article-title":"White matter integrity and processing speed in sickle cell anemia","volume":"90","author":"Stotesbury","year":"2018","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.jad.2024.08.222_bb0195","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/npp.2017.94","article-title":"Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression","volume":"42","author":"Su","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2024.08.222_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1176\/appi.neuropsych.15030053","article-title":"The links between stress and depression: psychoneuroendocrinological, genetic, and environmental interactions","volume":"28","author":"Tafet","year":"2016","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.08.222_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2018.07.003","article-title":"Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine","volume":"172","author":"Tian","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.jad.2024.08.222_bb0210","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41380-019-0477-2","article-title":"White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group","volume":"25","author":"van Velzen","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0924-977X(96)00042-9","article-title":"Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)","volume":"7","author":"Vollenweider","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2024.08.222_bb0220","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.brainresbull.2021.10.013","article-title":"(R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice","volume":"177","author":"Wang","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jad.2024.08.222_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105635","article-title":"(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: a role of gut-microbiota-brain axis","volume":"165","author":"Wang","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jad.2024.08.222_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104762","article-title":"(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: beyond depression","volume":"139","author":"Wang","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2024.08.222_bb0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.euroneuro.2021.04.010","article-title":"Intranasal administration of transforming growth factor-\u03b21 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: a role of TrkB signaling","volume":"50","author":"Wei","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0240","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2024.08.222_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psychres.2016.03.034","article-title":"Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine","volume":"239","author":"Yang","year":"2016","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0260","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176075","article-title":"The role and mechanism of TGF-\u03b21 in the antidepressant-like effects of tetrahydrocurcumin","volume":"959","author":"Yang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.jad.2024.08.222_bb0270","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","article-title":"Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine","volume":"27","author":"Yao","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2024.08.222_bb0275","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb0280","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R(\u2212)-ketamine shows greater potency and longer lasting antidepressant effects than S(+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.jad.2024.08.222_bb0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-020-0733-x","article-title":"Essential role of microglial transforming growth factor-\u03b21 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-\u03b21","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.222_bb0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41380-020-00930-0","article-title":"Oligodendrocyte lineage cells and depression","volume":"26","author":"Zhou","year":"2021","journal-title":"Mol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724014538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724014538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T03:32:57Z","timestamp":1729135977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724014538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":64,"alternative-id":["S0165032724014538"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.08.222","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-\u03b21","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.08.222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}